These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 886911)

  • 21. Scopolamine and adjunctive drinking in rats.
    Sanger DJ
    Psychopharmacology (Berl); 1976 Aug; 48(3):307-9. PubMed ID: 823587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug discrimination in rats: effects of mixtures of ditran and cholinesterase inhibitors.
    Järbe TU; Johansson JO
    Pharmacol Biochem Behav; 1976 Feb; 4(2):151-7. PubMed ID: 1265102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responses of thalamic neurones to iontophoretically applied drugs.
    McCance I; Phillis JW; Westerman RA
    Nature; 1966 Feb; 209(5024):715-6. PubMed ID: 5922134
    [No Abstract]   [Full Text] [Related]  

  • 24. Relearning at different times after training as affected by centrally and peripherally acting cholinergic drugs in the mouse.
    Squire LR; Glick SD; Goldfarb J
    J Comp Physiol Psychol; 1971 Jan; 74(1):41-5. PubMed ID: 5163699
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute effects of some drugs on the higher nervous activity in man. An interaction of physostigmine (1.0 mg) and scopolamine (0.6 mg applied 15 and 30 minutes after physostigmine). Part LV.
    Hrbek J; Macáková J; Komenda S; Siroká A; Hrbek J; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1986; 115():31-72. PubMed ID: 2951975
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of physostigmine and scopolamine on memory for food caches in the black-capped chickadee.
    Mineau P; Boag PT; Beninger RJ
    Pharmacol Biochem Behav; 1994 Oct; 49(2):363-70. PubMed ID: 7824551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of atropine, hyoscyamine, physostigmine and neostigmine on the electrical activity of the brain of the conscious cat.
    BRADLEY PB; ELKES J
    J Physiol; 1953 Apr; 120(1-2):14P-15P. PubMed ID: 13062251
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental manipulation of acetylcholine levels in developing rat brain: neurochemistry and behavior.
    Mathura CB; Meier GW; Himwich WA
    Psychol Rep; 1979 Dec; 45(3):811-8. PubMed ID: 538197
    [No Abstract]   [Full Text] [Related]  

  • 30. Temporal aspects of anticholinergic-and anticholinesterase-induced amnesia for an appetitive habit.
    Wiener N; Deutsch JA
    J Comp Physiol Psychol; 1968 Dec; 66(3):613-7. PubMed ID: 4305621
    [No Abstract]   [Full Text] [Related]  

  • 31. On acute effects of some drugs on the higher nervous activity in man. Scopolamine (0.6 mg), physostigmine (1.0 mg) and their interaction. Part LIII.
    Hrbek J; Macáková J; Komenda S; Siroká A; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1985; 112():185-226. PubMed ID: 2938435
    [No Abstract]   [Full Text] [Related]  

  • 32. On the interaction of drugs with the cholinergic nervous system--V. Characterization of some effects induced by physostigmine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1978 Jan; 27(2):203-11. PubMed ID: 623676
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of humoral modulators of morphine-induced increase in locomotor activity of mice.
    Oka T; Hosoya E
    Jpn J Pharmacol; 1976 Oct; 26(5):615-9. PubMed ID: 137340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze.
    Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
    Neurosci Lett; 1992 Sep; 144(1-2):79-83. PubMed ID: 1436716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pretrial and posttrial administration of cholinergic and anticholinergic drugs on spontaneous alternation.
    Squire LR
    J Comp Physiol Psychol; 1969 Sep; 69(1):69-75. PubMed ID: 5347369
    [No Abstract]   [Full Text] [Related]  

  • 36. [Depressive effects of physostigmine].
    Modestin J; Hunger J; Schwartz RB
    Arch Psychiatr Nervenkr (1970); 1973 Nov; 218(1):67-77. PubMed ID: 4588939
    [No Abstract]   [Full Text] [Related]  

  • 37. Berry CA: Effect of cholinergic drugs on passive avoidance in the mouse.
    Dilts SL
    J Pharmacol Exp Ther; 1967 Nov; 158(2):279-85. PubMed ID: 6065151
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential effects of cholinergic agonists on self-stimulation and escape behavior.
    Olds ME; Domino EF
    J Pharmacol Exp Ther; 1969 Nov; 170(1):157-67. PubMed ID: 5351000
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of scopolamine on the temporal control of behavior.
    Osborne SR; Rysberg J; Killeen P
    Physiol Behav; 1977 Jul; 19(1):79-85. PubMed ID: 11803696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physostigmine as a discriminative cue in rats.
    Johansson JO; Järbe TU
    Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):97-102. PubMed ID: 1267546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.